These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7521419

  • 1. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
    Nagayama R, Shoji S, Miyake K.
    Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
    [Abstract] [Full Text] [Related]

  • 2. [Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy].
    Kaji K, Unoura M, Kobayashi K, Nakanuma Y.
    Nihon Rinsho; 1994 Jul; 52(7):1865-8. PubMed ID: 7521432
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Jul; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 4. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N, Hayashi N, Ohkawa K, Hagiwara H, Oshita M, Katayama K, Sasaki Y, Kasahara A, Fusamoto H, Kamada T.
    Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
    [Abstract] [Full Text] [Related]

  • 5. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy].
    Osada T, Iwabuchi S, Takatori M, Murayama M, Iino S.
    Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414
    [Abstract] [Full Text] [Related]

  • 6. [Clinicopathological studies of anti-HCV P1P4 core antibody].
    Shibuya A, Asano A, Tsuchihashi T, Sakurai K, Takeuchi A, Shibata H.
    Rinsho Byori; 1995 Mar; 43(3):285-9. PubMed ID: 7538180
    [Abstract] [Full Text] [Related]

  • 7. [Intercalation monitoring PCR(IM-PCR), its principle and application: quantitative monitoring of HCV RNA in the course of IFN therapy].
    Ishiguro T, Saitoh J.
    Rinsho Byori; 1997 Mar; 45(3):213-7. PubMed ID: 9086823
    [Abstract] [Full Text] [Related]

  • 8. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T, Onji M, Michitaka K, Ohta Y.
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [Abstract] [Full Text] [Related]

  • 9. [The indication and the evaluation of IFN treatment of chronic hepatitis C].
    Yano M.
    Nihon Rinsho; 1994 Jul; 52(7):1778-83. PubMed ID: 7521417
    [Abstract] [Full Text] [Related]

  • 10. [Basic examination of hepatitis C virus (HCV) core protein quantitative method and the clinical significance in during the follow-up of the patients after interferon treatment].
    Suyama Y, Mishima S, Iwata Y, Ishikura H, Shibata H, Masuda J.
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1999 Jul; 10(1):13-9. PubMed ID: 10415445
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA, van Binsbergen J, Wang CY, Pardo M, Navas S, Trines C, Herrero M, Carreño V.
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [Abstract] [Full Text] [Related]

  • 12. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kuzuya T, Honda T, Hayashi K, Nakano I, Katano Y, Goto H.
    Clin Infect Dis; 2005 Mar 15; 40(6):e49-54. PubMed ID: 15736006
    [Abstract] [Full Text] [Related]

  • 13. [HCV-serotype and IFN response].
    Nakamura H, Kako M, Aikawa T, Mayumi M, Kanai K.
    Nihon Rinsho; 1994 Jul 15; 52(7):1734-7. PubMed ID: 7521412
    [Abstract] [Full Text] [Related]

  • 14. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA, Bailly F, Si-Ahmed SN, Chevallier P, Sepetjan M, Colucci G, Trépo C.
    J Med Virol; 1997 May 15; 52(1):105-12. PubMed ID: 9131466
    [Abstract] [Full Text] [Related]

  • 15. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G, Cariani E, Lamonaca V, Ravaggi A, Rossini A, Bertoni R, Houghton M, Matsuura Y, Miyamura T, Fiaccadori F, Ferrari C.
    Hepatology; 1997 Sep 15; 26(3):792-7. PubMed ID: 9303515
    [Abstract] [Full Text] [Related]

  • 16. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
    Lunel F, Cresta P, Vitour D, Payan C, Dumont B, Frangeul L, Reboul D, Brault C, Piette JC, Huraux JM.
    Hepatology; 1999 Feb 15; 29(2):528-35. PubMed ID: 9918931
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S, Yokosuka O, Imazeki F, Saisho H, Mizuno C.
    J Med Virol; 2002 Nov 15; 68(3):343-51. PubMed ID: 12226820
    [Abstract] [Full Text] [Related]

  • 18. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R, Miyake K, Tsuda F, Okamoto H.
    J Med Virol; 1994 Mar 15; 42(3):311-7. PubMed ID: 7516423
    [Abstract] [Full Text] [Related]

  • 19. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
    Leroux-Roels G, Esquivel CA, DeLeys R, Stuyver L, Elewaut A, Philippé J, Desombere I, Paradijs J, Maertens G.
    Hepatology; 1996 Jan 15; 23(1):8-16. PubMed ID: 8550052
    [Abstract] [Full Text] [Related]

  • 20. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy.
    Zanetti AR, Romanò L, Brunetto M, Colombo M, Bellati G, Tackney C.
    J Med Virol; 2003 May 15; 70(1):27-30. PubMed ID: 12629640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.